Mandell LA - Search Results

1

Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC.

Ball AP, Bartlett JG, Craig WA, Drusano GL, Felmingham D, Garau JA, Klugman KP, Low DE, Mandell LA, Rubinstein E, Tillotson GS. Ball AP, et al. Among authors: mandell la. J Chemother. 2004 Oct;16(5):419-36. doi: 10.1179/joc.2004.16.5.419. J Chemother. 2004. PMID: 15565907 Review.

2

A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

Ball P, Mandell L, Patou G, Dankner W, Tillotson G. Ball P, et al. Int J Antimicrob Agents. 2004 May;23(5):421-9. doi: 10.1016/j.ijantimicag.2004.02.014. Int J Antimicrob Agents. 2004. PMID: 15120718 Review.

3

Adverse cutaneous reactions and drugs: a focus on antimicrobials.

Iannini P, Mandell L, Felmingham J, Patou G, Tillotson GS. Iannini P, et al. J Chemother. 2006 Apr;18(2):127-39. doi: 10.1179/joc.2006.18.2.127. J Chemother. 2006. PMID: 16736880 Review.

4

Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in mice.

Bast DJ, Dresser L, Duncan CL, Walker SE, Mandell LA, Low DE, de Azavedo JC. Bast DJ, et al. Among authors: mandell la. J Chemother. 2006 Dec;18(6):634-40. doi: 10.1179/joc.2006.18.6.634. J Chemother. 2006. PMID: 17267342

5

The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?

Mandell LA, Peterson LR, Wise R, Hooper D, Low DE, Schaad UB, Klugman KP, Courvalin P. Mandell LA, et al. Clin Infect Dis. 2002 Sep 15;35(6):721-7. doi: 10.1086/341900. Epub 2002 Aug 20. Clin Infect Dis. 2002. PMID: 12203170

6

Comparative tolerability of the newer fluoroquinolone antibacterials.

Ball P, Mandell L, Niki Y, Tillotson G. Ball P, et al. Drug Saf. 1999 Nov;21(5):407-21. doi: 10.2165/00002018-199921050-00005. Drug Saf. 1999. PMID: 10554054 Review.

7

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.

File TM Jr, Mandell LA, Tillotson G, Kostov K, Georgiev O. File TM Jr, et al. Among authors: mandell la. J Antimicrob Chemother. 2007 Jul;60(1):112-20. doi: 10.1093/jac/dkm119. Epub 2007 May 30. J Antimicrob Chemother. 2007. PMID: 17537866 Clinical Trial.

8

Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.

File TM Jr, Garau J, Blasi F, Chidiac C, Klugman K, Lode H, Lonks JR, Mandell L, Ramirez J, Yu V. File TM Jr, et al. Chest. 2004 May;125(5):1888-901. doi: 10.1378/chest.125.5.1888. Chest. 2004. PMID: 15136404 Review.

9

Respiratory fluoroquinolones: differences in the details.

Mandell LA, Iannini PB, Tillotson GS. Mandell LA, et al. Clin Infect Dis. 2004 May 1;38(9):1331-2; author reply 1332-3. doi: 10.1086/383153. Clin Infect Dis. 2004. PMID: 15127351 No abstract available.

10

The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance.

Peyrani P, Mandell L, Torres A, Tillotson GS. Peyrani P, et al. Expert Rev Respir Med. 2019 Feb;13(2):139-152. doi: 10.1080/17476348.2019.1562339. Epub 2018 Dec 30. Expert Rev Respir Med. 2019. PMID: 30596308 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page